Van Meer, Axel
Gilis, Jacques
Oosterlinck, Baptiste
Vandamme, Timon
De Man, Joris
De Winter, Benedicte Y.
Smet, Annemieke https://orcid.org/0000-0002-1271-6191
Funding for this research was provided by:
Universiteit Antwerpen (FFB240455)
Universiteit Antwerpen (FFI230207)
Universiteit Antwerpen (FFI230207)
Universiteit Antwerpen (FFI230207)
Fonds Wetenschappelijk Onderzoek (1803723N)
Article History
Received: 11 August 2025
Revised: 29 October 2025
Accepted: 14 November 2025
First Online: 27 November 2025
Competing interests
: AS and BYDW are inventors of patent applications related to mucin isoforms in diseases characterized by barrier dysfunction, including GI cancers (WO/2021/013479; WO2025/120137). All other authors declare no conflict of interest.